共 52 条
- [1] Rawla P., Sunkara T., Gaduputi V., Epidemiology of pancreatic cancer: global trends, etiology and risk factors, World J Oncol, 10, 1, (2019)
- [2] Partyka O., Pajewska M., Kwasniewska D., Czerw A., Deptala A., Budzik M., Et al., Overview of pancreatic cancer epidemiology in Europe and recommendations for screening in high-risk populations, Cancers, 15, 14, (2023)
- [3] Weller D., Vedsted P., Rubin G., Walter F., Emery J., Scott S., Et al., The Aarhus statement: improving design and reporting of studies on early cancer diagnosis, Br J Cancer, 106, 7, pp. 1262-1267, (2012)
- [4] Wolfgang C.L., Herman J.M., Laheru D.A., Klein A.P., Erdek M.A., Fishman E.K., Et al., Recent progress in pancreatic cancer, CA: Cancer J Clin, 63, 5, pp. 318-348, (2013)
- [5] Zagon I.S., Smith J.P., McLAUGHLIN P.J., Human pancreatic cancer cell proliferation in tissue culture is tonically inhibited by opioid growth factor, Int J Oncol, 14, 3, pp. 577-661, (1999)
- [6] Abrams R.A., Role of radiation therapy in the management of the patient with pancreatic cancer, Oncology (Williston Park), 10, 9 Suppl, pp. 13-17, (1996)
- [7] Carmichael J., Clinical response benefit in patients with advanced pancreatic cancer: role of gemcitabine, Digestion, 58, 6, pp. 503-507, (1997)
- [8] Mofid M.R., Gheysarzadeh A., Bakhtiyari S., Insulin-like growth factor binding protein 3 chemosensitizes pancreatic ductal adenocarcinoma through its death receptor, Pancreatology, 20, 7, pp. 1442-1450, (2020)
- [9] Andren-Sandberg A., Backman P., Hormonal therapy and immunotherapy, Surgical diseases of the pancreas, pp. 613-622, (1998)
- [10] Kamisawa T., Wood L.D., Itoi T., Takaori K., Pancreatic cancer, The Lancet, 388, pp. 73-85, (2016)